Mercy Hospital Oklahoma City
Oklahoma City, Oklahoma, United States
Hospital in Oklahoma City, Oklahoma
4300 W Memorial Rd, Oklahoma City, OK 73120
About Mercy Hospital Oklahoma City
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
98
Alliance for Clinical Trials in Oncology
33
SWOG Cancer Research Network
31
ECOG-ACRIN Cancer Research Group
19
NRG Oncology
9
Wake Forest University Health Sciences
7
NSABP Foundation Inc
3
Celgene
1
Eastern Cooperative Oncology Group
1
GOG Foundation
1
Genentech, Inc.
1
Clinical Trials at Mercy Hospital Oklahoma City
During the past decade, Mercy Hospital Oklahoma City conducted 155 clinical trials. In the 10-year time frame, 155 clinical trials started and 54 clinical trials were completed, i.e. on
average, 34.8% percent of trials that started reached the finish line to date. In the past 5 years, 48 clinical trials started and 34 clinical trials were completed. i.e. 70.8%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
1999-05-01
2012-08-01
Completed
19,747
Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy
2003-01-01
2016-05-01
Completed
3,104
Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer)
2003-10-01
2012-11-01
Completed
732
A Safety and Efficacy Study for Treatment of Painful Vertebral Compression Fractures Caused by Osteoporosis
2004-09-01
2009-03-01
Unknown status
256
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
2006-04-07
2030-09-30
Active, not recruiting
10,273
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery
2007-06-01
2023-10-16
Active, not recruiting
1,501
Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
2007-11-02
Active, not recruiting
4,994
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Mercy Hospital Oklahoma City" #1 sponsor was "National Cancer Institute (NCI)" with 98 trials, followed by "Alliance for Clinical Trials in Oncology" with 33 trials
sponsored, "SWOG Cancer Research Network" with 31 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 19 trials sponsored and "NRG Oncology"
with 19 trials sponsored. Other sponsors include 17 different institutions and
companies that sponsored additional 19 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Mercy Hospital Oklahoma City"
#1 collaborator was "National Cancer Institute (NCI)" with 105 trials as a collaborator, "NRG Oncology" with 15 trials as a collaborator, "Canadian Cancer Trials Group" with 10 trials as a collaborator, "North Central Cancer Treatment Group" with 4 trials as a collaborator and "Cancer and Leukemia Group B" with 3 trials as a collaborator. Other collaborators include 33 different institutions and companies that were
collaborators in the rest 35 trials.
Clinical Trials Conditions at Mercy Hospital Oklahoma City
According to Clinical.Site data, the most researched conditions in "Mercy Hospital Oklahoma City" are
"Stage IV Lung Cancer AJCC v8" (12 trials), "Invasive Breast Carcinoma" (10 trials), "Recurrent Lung Non-Small Cell Carcinoma" (8 trials), "Stage IVA Lung Cancer AJCC v8" (8 trials) and "Stage IVB Lung Cancer AJCC v8" (8 trials). Many other conditions were trialed in "Mercy Hospital Oklahoma City" in a lesser frequency.
Clinical Trials Intervention Types at Mercy Hospital Oklahoma City
Most popular intervention types in "Mercy Hospital Oklahoma City" are "Drug" (157 trials), "Other" (118 trials), "Biological" (86 trials), "Procedure" (66 trials) and "Radiation" (35 trials). Other intervention types were less common.
The name of intervention was led by "Quality-of-Life Assessment" (51 trials), "Laboratory Biomarker Analysis" (47 trials), "Questionnaire Administration" (39 trials), "Biospecimen Collection" (35 trials) and "Computed Tomography" (32 trials). Other intervention names were less common.
Clinical Trials Genders at Mercy Hospital Oklahoma City
The vast majority of trials in "Mercy Hospital Oklahoma City" are
184 trials for "All" genders, 24 trials for "Female" genders and 4 trials for "Male" genders.
Clinical Trials Status at Mercy Hospital Oklahoma City
Currently, there are NaN active trials in "Mercy Hospital Oklahoma City".
undefined are not yet recruiting,
76 are recruiting,
91 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 31 completed trials in Mercy Hospital Oklahoma City,
8 suspended trials,
and 5 terminated clinical trials to date.
Out of the total trials that were conducted in Mercy Hospital Oklahoma City, 4 "Phase 1"
clinical trials were conducted, 101 "Phase 2" clinical
trials and 101 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 8 trials that are defined as “Not Applicable".